Intelligence / Healthtech / FDA 510(k) Clearances / BIOMERIEUX, Inc.
BIOMERIEUX, Inc.
4 Nov 2026: Device cleared · VITEK 2 AST-Gram Negative Polymyxin B (<= 0.25 >=16µg/mL);VITEK 2 AST-Gram Negative Imipenem (<= 0.25 >=16µg/mL);VITEK 2 AST-Gram Negative Ceftazidime Avibactam (<= 0.125 >=16µg/mL). Recorded in the openFDA device 510(k) data.
- Decided
- 4 Nov 2026
- Device
- VITEK 2 AST-Gram Negative Polymyxin B (<= 0.25 >=16µg/mL);VITEK 2 AST-Gram Negative Imipenem (<= 0.25 >=16µg/mL);VITEK 2 AST-Gram Negative Ceftazidime Avibactam (<= 0.125 >=16µg/mL)
- Specialty
- Microbiology
- Country
- United States
- Location
- Hazelwood, MO
- Clearance type
- Traditional
- 510(k) number
- K262807
- Submitted
- 2026-08-07
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Find the decision makers at BIOMERIEUX, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for BIOMERIEUX, Inc. in our registers.
More in Microbiology
FDA 510(k) Clearances
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.